home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

260 rows where filing_period = "third_quarter", filing_year = 2012 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: is_termination, received_date (date)

issue_code 1

  • MED · 260 ✖

filing_year 1

  • 2012 · 260 ✖

filing_period 1

  • third_quarter · 260 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1293644 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c56f3f7a-3b30-4900-8308-ff42517a69db 3T CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TETHYS BIOSCIENCE 2012 third_quarter MED Regulation and reimbursement of laboratory developed tests. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2012-08-24T13:11:00.347000-04:00
1293926 KSCW, INC. b7abe00d-2ef4-4cea-9506-a8a7c3d92121 3T KSCW, INC. 21596 INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS 2012 third_quarter MED S.3187: Food and Drug Administration Safety and Innovation Act, Provisions affecting the Medical device industry H.R.436: Health Care Cost Reduction Act of 2012 provisions related to the medical device excise tax S.262 A bill to repeal the excise tax on medical device manufacturers. HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2012-09-04T15:15:57.380000-04:00
1294703 MARSHALL BRACHMAN 1efcf4fd-289b-4543-b255-9ed3f41b9743 Q3 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2012 third_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2012-10-01T10:45:21.060000-04:00
1294892 THE HARRIS FIRM 87be6ded-0bf6-4822-ad84-6f8c67c24ba1 Q3 THE HARRIS FIRM 68376 DIRECT MESSAGE LAB 2012 third_quarter MED Regarding funding pertaining to software communication system for chronic disease management. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-10-02T10:25:18.823000-04:00
1294909 PALMETTO GROUP 4837780a-b92d-4e27-b284-1de7d35ac73b Q3 PALMETTO GROUP 18570 INTERNATIONAL AIDS VACCINE INITIATIVE 2012 third_quarter MED Federal Funding of AIDS vaccine S.3241 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2013 SENATE 22500   0 0 2012-10-02T10:54:30.803000-04:00
1294933 FEDERAL SOLUTIONS, LLC 61c20c67-fb6b-4e26-b84c-b988f2572b8a Q3 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2012 third_quarter MED Labor/HHS/Education Appropriations Bill 2012: Provisions relating to disease research, education, and development HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-02T11:40:43.953000-04:00
1294955 FEDERAL SOLUTIONS, LLC cc879ff9-72f6-4c59-9fc9-9634faa68408 Q3 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2012 third_quarter MED Labor/HHS/Education Appropriations Bill 2012: Provisions relating to disease research Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2012-10-02T11:42:48.153000-04:00
1295151 AMERICAN COLLEGE OF CLINICAL PHARMACY 8ee1d045-b7b2-479a-a8a7-ec8038ded7c7 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2012 third_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   61700 0 0 2012-10-03T11:38:48.013000-04:00
1295219 THOMPSON HINE LLP 2e351b79-4bc4-4436-94ea-a16073fe238c Q3 THOMPSON HINE LLP 38051 TEXAS BIOMEDICAL RESEARCH INSTITUTE 2012 third_quarter MED Legislative and regulatory matters regarding the use of chimpanzees in biomedical research (i.e., the Great Ape Protection and Cost Savings Act and possible "endangered species" designation for chimpanzees by the U.S. Fish and Wildlife Service). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-10-03T15:42:36.757000-04:00
1295414 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) c14d7914-5a0c-40e6-b795-ea235af4edee Q3 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2012 third_quarter MED all matters dealing with pharmaceutical labeling Food & Drug Administration (FDA) 25000   0 0 2012-10-04T14:45:29.110000-04:00
1295417 GRIZZLE COMPANY 72f83c71-1c13-4dc5-95b0-4914d4e85d82 Q3 GRIZZLE COMPANY 16987 UNIVERSITY OF LOUISVILLE 2012 third_quarter MED Request support for NIH grant application   40000   0 0 2012-10-04T14:46:30.187000-04:00
1295549 PARRY, ROMANI, DECONCINI & SYMMS 3f79de6a-bc6a-4cc4-83d6-6dab786f391c Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2012 third_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-10-05T13:14:14.943000-04:00
1295559 PARRY, ROMANI, DECONCINI & SYMMS 88c9c96b-fbd1-48d7-933a-152ef81527bd Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2012 third_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2012-10-05T13:35:19.340000-04:00
1295580 PARRY, ROMANI, DECONCINI & SYMMS 508810e1-0f7b-494c-afef-7241dc4e60f0 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2012 third_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-10-05T14:39:33.297000-04:00
1295591 PARRY, ROMANI, DECONCINI & SYMMS 2f46c21f-df05-402f-b105-0ba48de4a478 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2012 third_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-10-05T14:45:38.743000-04:00
1295602 PARRY, ROMANI, DECONCINI & SYMMS 1488395d-1238-473b-9275-c49f2224b83a Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2012 third_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-10-05T14:53:44.530000-04:00
1295676 CAPITOL CONSULTING GROUP, LLC 3c0a29e9-2db4-4dd5-9d40-f8b3f0324c53 Q3 CAPITOL CONSULTING GROUP, LLC 400366700 TERUMO BCT (FORMERLY CARIDIANBCT BIOTECHNOLOGIES LLC) 2012 third_quarter MED Blood pathogen reduction technology development HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-07T19:47:29.497000-04:00
1295732 UNIVERSITY OF IOWA 8598c359-ca70-4cac-9da3-4c906139fc9a Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2012 third_quarter MED FY 2011 Appropriations Residency Caps FY 2012 Appropriations Minority Improvement Medical Affordability Act False Claims Correction Act Research Misconduct Clinical Trials NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act Prevention Research Centers Resident Physician Shortage Health Care Reform FY 2013 Appropriations Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   88684 0 0 2012-10-08T10:26:43.090000-04:00
1295881 CAPITOL CONSULTING GROUP, LLC 64ab44eb-ee70-47cd-bb1d-7516ac25e047 Q3 CAPITOL CONSULTING GROUP, LLC 400366700 HUMACYTE INCORPORATED 2012 third_quarter MED Research and development of products for vascular disease and for therapeutic filling and soft tissue repair HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-08T16:11:10.420000-04:00
1296164 PARRY, ROMANI, DECONCINI & SYMMS 33a9e998-7bb3-4560-a758-056964a20ebb Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2012 third_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 - Support funding for medical treatment for HIV positive patients. Support appropriate funding for the ADAP program. Continue appropriate funding for Chronic Care Special Needs clinics under Medicare. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-09T16:24:36.550000-04:00
1296325 DENNY MILLER ASSOCIATES 488bd6ed-7a7e-4cd5-9bd7-ef1f1b31493f Q3 DENNY MILLER ASSOCIATES 25328 SABEY CORPORATION 2012 third_quarter MED Federal grant funding for medical education and research facilities. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-10T10:50:54.020000-04:00
1296377 AMERICAN ASSOCIATION FOR CANCER RESEARCH 22e2c0bc-17cf-4468-a5d1-49d5d62a153c Q3 AMERICAN ASSOCIATION FOR CANCER RESEARCH 400601833 AMERICAN ASSOCIATION FOR CANCER RESEARCH 2012 third_quarter MED H.R. 733/S. 362, the Pancreatic Cancer Research and Education Act and its substitute, the Recalcitrant Cancer Act of 2012 HOUSE OF REPRESENTATIVES,SENATE   25000 0 0 2012-10-10T11:21:09.450000-04:00
1296597 ASSN OF MEDICAL DEVICE REPROCESSORS 1a806cf8-25ed-42be-84bf-0769318f1885 Q3 ASSN OF MEDICAL DEVICE REPROCESSORS 291732 ASSN OF MEDICAL DEVICE REPROCESSORS 2012 third_quarter MED Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally. Initiated discussions on MDUFA reauthorization. Contacted VA about hospital regulations for reprocessed single-use medical devices. Commerce, Dept of (DOC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. International Trade Commission (ITC),Veterans Affairs, Dept of (VA)   20000 0 0 2012-10-10T14:50:57.877000-04:00
1297376 PETERSON GROUP (FL) 24b2382d-07f9-4deb-918d-675584f7d756 Q3 PETERSON GROUP (FL) 400920675 CLEVELAND BIOLABS, INC. 2012 third_quarter MED Homeland security, civil defense, and health issues involving nuclear radiation exposure. Creating Congressional awareness of nuclear radiation threats and need to support speedy development of countermeasures. No specific legislation at this time. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-11T20:09:24.300000-04:00
1297417 LNE GROUP 8d4d624e-a864-4084-931e-5d979116566a Q3 LNE GROUP 308811 OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) 2012 third_quarter MED Lobbied for issues within the medical field including reseach, and clinical labs HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-12T09:32:49.483000-04:00
1297466 LNE GROUP 0f546b81-9adb-46cc-a16d-0666d835e171 Q3 LNE GROUP 308811 INTRINSIQ MATERIALS 2012 third_quarter MED Lobbied for issues regarding the medical research HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-12T10:17:13.837000-04:00
1297554 WAKE FOREST UNIVERSITY HEALTH SCIENCES 0b2ed80c-4698-4cc0-80c4-93fb534529ea Q3 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2012 third_quarter MED NIH Budget including Title VII & VIII programs VA-Outpatient Clinic in N.C.(RFP-land acquisition) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   145000 0 0 2012-10-12T11:06:43.843000-04:00
1297765 LNE GROUP f05ebfd6-ff0c-42ba-b941-2c6c6e1bb44d Q3 LNE GROUP 308811 ZIMMER 2012 third_quarter MED Lobbied for medical device issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-12T13:24:46.227000-04:00
1297791 INTERNATIONAL MYELOMA FOUNDATION 4cb1b891-c525-4c3e-b3b7-c2e28428dc99 Q3 INTERNATIONAL MYELOMA FOUNDATION 400595820 INTERNATIONAL MYELOMA FOUNDATION 2012 third_quarter MED HR 2746, Cancer Drug Coverage Parity Act HOUSE OF REPRESENTATIVES,SENATE   50500 0 0 2012-10-12T13:53:02.680000-04:00
1297846 THOMPSON HINE LLP d199be5f-a378-4df3-9d91-23cb6915da46 Q3 THOMPSON HINE LLP 38051 NEW IBERIA RESEARCH CENTER -- UNIVERSITY OF LOUISIANA AT LAFAYETTE 2012 third_quarter MED Legislative and regulatory matters regarding the use of chimpanzees in biomedical research (i.e., the Great Ape Protection and Cost Savings Act and possible "endangered species" designation for chimpanzees by the U.S. Fish and Wildlife Service). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-10-12T14:32:25.820000-04:00
1297946 LATHAM & WATKINS LLP deb99f49-e730-4091-94b7-b639e29f754e Q3 LATHAM & WATKINS LLP 22201 BOSTON SCIENTIFIC CORPORATION 2012 third_quarter MED Congressional oversight of the Food and Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-12T15:52:15.290000-04:00
1298119 BEN BARNES GROUP LP 6ce17f29-fccd-4c9f-908c-b4260ee24ed3 Q3 BEN BARNES GROUP LP 5415 FAIR LABORATORY PRACTICES ASSOCIATION 2012 third_quarter MED Bring attention to prevention of unfair billing practices by laboratories for Medicare services SENATE 30000   0 0 2012-10-13T12:34:30.763000-04:00
1298125 BEN BARNES GROUP LP ec816d36-104d-494d-b600-dd44ab09251b Q3 BEN BARNES GROUP LP 5415 OKLAHOMA RESEARCH MEDICAL FOUNDATION 2012 third_quarter MED IDEA funding for smaller states SENATE 20100   0 0 2012-10-13T13:19:35.650000-04:00
1298137 BEN BARNES GROUP LP d339769b-0562-4f4c-b216-4ba71d4781be Q3 BEN BARNES GROUP LP 5415 ROYALTY PHARMA - / RP MANAGEMENT, LLC 2012 third_quarter MED Correct publicly traded partnership rules on passive income HOUSE OF REPRESENTATIVES,SENATE 150000   0 0 2012-10-13T14:23:42.333000-04:00
1299015 DENNY MILLER ASSOCIATES d15869e2-bfcd-4dfa-8a89-eab28aa0fa78 Q3 DENNY MILLER ASSOCIATES 25328 CELL THERAPEUTICS 2012 third_quarter MED S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-15T13:55:42.557000-04:00
1299616 WEBMD HEALTH CORP. 8397a812-5013-4f2d-953c-a0caf9229729 Q3 WEBMD HEALTH CORP. 55473 WEBMD HEALTH CORP 2012 third_quarter MED Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts. Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and the deduction of expenses associated with advertising; Personal health records. SENATE   30000 0 0 2012-10-15T17:28:52.837000-04:00
1300071 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH c63ebfbf-1a54-471f-9eb0-b3055cbe807b Q3 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2012 third_quarter MED Support for the National Eye Institute at the National Institues of Health; Support for medical research programs at the Department of Defense HOUSE OF REPRESENTATIVES,SENATE   61500 0 0 2012-10-16T09:43:16.490000-04:00
1300198 PRINCETON UNIVERSITY 74d438d8-5088-4e56-b8a6-51b42ac26840 Q3 PRINCETON UNIVERSITY 308695 PRINCETON UNIVERSITY 2012 third_quarter MED S. 810; H.R. 1513: Great Ape Protection and Cost Savings Act of 2011 Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,White House Office   30000 0 0 2012-10-16T10:51:06.330000-04:00
1300241 INFECTIOUS DISEASES SOCIETY OF AMERICA bbcd83a6-23ce-45db-89b9-8f3a14d75ee4 Q3 INFECTIOUS DISEASES SOCIETY OF AMERICA 54836 INFECTIOUS DISEASES SOCIETY OF AMERICA 2012 third_quarter MED Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policy to allow HIV+ to HIV+ organ transplants Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID)   87400 0 0 2012-10-16T11:12:40.430000-04:00
1300449 WASHINGTON UNIVERSITY IN ST. LOUIS 5f97b9a4-b547-45b5-9aa2-698214e287d6 Q3 WASHINGTON UNIVERSITY IN ST. LOUIS 40031264 WASHINGTON UNIVERSITY IN ST LOUIS 2012 third_quarter MED General advocacy for NIH research, genomics research, and improved conflict of interest policies. Advocacy in support of clear, productive federal stem cell research guidelines. HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE   30000 0 0 2012-10-16T12:30:42.807000-04:00
1300531 MEHLMAN CONSULTING, INC. 0b0fe808-c8ff-47a5-947f-f783fc250a53 Q3 MEHLMAN CONSULTING, INC. 284950 NATIONAL VENTURE CAPITAL ASSOCIATION 2012 third_quarter MED FDA reform: Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs. H.R. 4132, Faster Access to Specialized Treatments (FAST) Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act; H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011; S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012 (See continuation page) H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. (Became Public Law 112-144) Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of 60000   0 0 2012-10-16T13:02:38.363000-04:00
1300835 DALRYMPLE & ASSOCIATES, LLC 475070b6-8fdb-4556-8b7d-7a9949282b77 Q3 DALRYMPLE & ASSOCIATES, LLC 5073 EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) 2012 third_quarter MED Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 63000   0 0 2012-10-16T14:26:43.990000-04:00
1300848 DALRYMPLE & ASSOCIATES, LLC 81002137-4bdd-494e-857c-db18ccd21393 Q3 DALRYMPLE & ASSOCIATES, LLC 5073 SANOFI PASTEUR 2012 third_quarter MED Vaccine research and development legislation, funding, appropriations and oversight. Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office 46000   0 0 2012-10-16T14:31:52.140000-04:00
1300868 DALRYMPLE & ASSOCIATES, LLC da3cea94-bfd6-4544-a532-029667ab201c Q3 DALRYMPLE & ASSOCIATES, LLC 5073 DISCOVERY LABORATORIES 2012 third_quarter MED Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 16000   0 0 2012-10-16T14:35:58.683000-04:00
1301072 POLICY DIRECTIONS INC. 3285bdb5-e4d7-4db4-8c44-b0ebed270712 3T POLICY DIRECTIONS INC. 31747 BAYLOR COLLEGE OF MEDICINE 2012 third_quarter MED S. 606 and HR 3059- Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment. HR 528 - Neglected Infections of Impoverished Americans Act of 2011. HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2012-10-16T15:16:15.907000-04:00
1301108 POLICY DIRECTIONS INC. 0e0e0ad0-391b-4ecd-936d-f1a663bced01 Q3 POLICY DIRECTIONS INC. 31747 COVANCE INC 2012 third_quarter MED No Bills. Issues related to FDA regulatory requirements for product testing. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-16T15:19:24.733000-04:00
1301174 MEHLMAN CONSULTING, INC. 357410b0-0f85-4e98-b455-8fece96f843e Q3 MEHLMAN CONSULTING, INC. 284950 AMERICAN CLINICAL LABORATORY ASSOCIATION 2012 third_quarter MED Health reform law implementation issues including application of medical device tax to clinical laboratory tests and laboratory fee schedule. In-office ancillary services exception to Stark Law. H.R. 3207, The Modernizing Laboratory Test Standards for Patients Act. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 60000   0 0 2012-10-16T15:29:54.643000-04:00
1301329 PHILIP W. JOHNSTON ASSOCIATES 6d6ddc9f-8b21-4f8d-a2a7-796229fb4291 Q3 PHILIP W. JOHNSTON ASSOCIATES 400278335 JUSTICE RESOURCE INSTITUTE 2012 third_quarter MED Issues related to National Child Traumatic Stress Network. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-10-16T16:30:14.110000-04:00
1301431 AMERICAN ACADEMY OF FAMILY PHYSICIANS 612fe9b3-409e-48cf-80f1-f00ffe84cf14 Q3 AMERICAN ACADEMY OF FAMILY PHYSICIANS 1342 AMERICAN ACADEMY OF FAMILY PHYSICIANS 2012 third_quarter MED H.R.5888, Physician Reentry Demonstration Program, Bill attempts to address the shortage of primary care physicians. Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office   449038 0 0 2012-10-16T16:53:55.267000-04:00
1301481 AMERICAN ASSOCIATION FOR HOMECARE 79a0704b-9e3d-4f6f-8094-8d316a32836a Q3 AMERICAN ASSOCIATION FOR HOMECARE 55792 AMERICAN ASSOCIATION FOR HOMECARE 2012 third_quarter MED Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabeti supplies, negative pressure wound therapy, Medicare audits, and fraud abuse; H.R. 1041 - Fairness in Medicare Bidding Act, all provisions; H.R. 3399/S. 1251 - Medicare and Medicaid FAST Act, all provisions; H.R. 452 - Medicare Decisions Accountability Act of 2011, all provisions; S.668 - Health Care Bureaucrats Elimination Act, all provisions; H.R. 3630 - Middle Class Tax Relief and Job Creation Act of 2012, all provisions; H.Con.Res. 112 - House Budget Resolution for Fiscal Year 2013, all provisions; S.3187 - Food and Drug Administration Safety and Innovation Act, all provisions; H.R. 4378 - Ensuring Access to Quality Complex Rehabilitation Technology Act of 2012, all provisions; H.R. 5652 - Sequester Replacement Reconciliation Act of 2012, issues pertaining to Medicare; CMS prior authorization demonstration for power mobility devices. H.R. 6490 - Medicare DMEPOS Market Pricing Program Act of 2012, all provisions. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Natl Economic Council (NEC),Office of Management & Budget (OMB),SENATE,Treasury, Dept of,White House Office   170000 0 0 2012-10-16T17:36:25.827000-04:00
1301630 VAN SCOYOC ASSOCIATES 7673e8bf-d370-4e86-8491-cebfbd86d126 Q3 VAN SCOYOC ASSOCIATES 39837 ELECTROCHEMICAL OXYGEN CONCEPTS, INC. DBA EO2 CONCEPTS 2012 third_quarter MED No lobbying activity. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-17T06:39:52.180000-04:00
1301635 VAN SCOYOC ASSOCIATES 5b98ba51-e4ce-4bc9-98f9-e1b5ca0fe4cc Q3 VAN SCOYOC ASSOCIATES 39837 MEDICINES FOR MALARIA VENTURE 2012 third_quarter MED USAID and Malaria research and development issues and initiatives HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-17T06:43:54.130000-04:00
1301822 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c0db0334-9cb5-424a-b20e-6c9b2ef8fa40 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2012 third_quarter MED S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, Tuberous Sclerosis HR 5856, Defense Appropriations, FY 2013 Defense health programs, Tuberous Sclerosis Complex Research Program HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2012-10-17T09:36:15.270000-04:00
1301882 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d26fdf7b-8fdd-4506-a52e-612a81dee493 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 SAGE PUBLICATIONS, INC. 2012 third_quarter MED HR4004, S.2096, Federal Research Public Access Act; National Institutes of Health Open Access policy No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, NIH Open Access Policy, Department of Education Title II Funding HR3699, Research Works Act No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-17T09:51:42.363000-04:00
1301895 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 20b3a907-3f78-4d00-a0cb-432fb2a97059 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION 2012 third_quarter MED S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2012-10-17T09:56:48.590000-04:00
1301937 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4e39664a-ec22-4a89-9990-fc96d783377e Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 DIADEXUS INC 2012 third_quarter MED H.R. 436 Health Care Cost Reduction Act Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act Reimbursement of laboratory tests HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-17T10:06:09.420000-04:00
1301955 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 03b7d63d-e29e-4296-8670-388d1adab116 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 CRESCENDO BIOSCIENCE INC. 2012 third_quarter MED Biomedical research, treatment of rheumatoid arthritis, public-private partnerships, oversight and reimbursement of laboratory testing. HR 436, Health Care Cost Reduction Act HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2012-10-17T10:09:15.557000-04:00
1301984 NORTHWESTERN UNIV 3d04c802-5466-4595-8121-ea7d8921d561 Q3 NORTHWESTERN UNIV 299992 NORTHWESTERN UNIV 2012 third_quarter MED H.R. 2146, The Digital Accountability and Transparency Act, entire bill S. 1627, Resident Physician Shortage Act of 2011, entire bill H.R. 3433, The Grant Reform and Transparency Act of 2011, The Grant Act, entire bill H.R. 3699, The Research Works Act, entire bill S. 2096/H.R. 4004, Federal Research Public Access Act, entire bill HOUSE OF REPRESENTATIVES,SENATE   86000 0 0 2012-10-17T10:15:25.610000-04:00
1301990 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 08342c17-6f3b-4af9-9d88-983bb6170ccb Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2012 third_quarter MED Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 30000   0 0 2012-10-17T10:16:27.250000-04:00
1302021 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5fa0d8ae-c11b-4f21-9e06-7929ba2d1ab3 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ONYX PHARMACEUTICALS 2012 third_quarter MED Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages. Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-10-17T10:23:40.740000-04:00
1302023 SRI INTERNATIONAL 7155ac94-9880-4141-9fee-6b88b45f99f5 Q3 SRI INTERNATIONAL 90990 SRI INTERNATIONAL 2012 third_quarter MED Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (HR 2405, S 1855) FY 13 House and Senate Labor/HHS/Education Appropriations (S 3295) HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2012-10-17T10:23:41.803000-04:00
1302031 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 83345244-bba1-41d2-a0b0-7db6233da765 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 INTERNATIONAL MYELOMA FOUNDATION 2012 third_quarter MED HR 2746 Cancer Drug Coverage Parity Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-17T10:26:45.317000-04:00
1302191 THE PETRIZZO GROUP, INC. 1c710388-bb1b-498a-a6d6-10902e79f5c6 3T THE PETRIZZO GROUP, INC. 305932 SAGE THERAPEUTICS, INC. 2012 third_quarter MED Advocated for federal funding to support development of neuroactive steroids research yielding therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain. Defense, Dept of (DOD) 10000   0 1 2012-10-17T10:57:34.887000-04:00
1302194 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 0e83a118-fdb8-4e94-ab65-81ceadc3fb9e Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2012 third_quarter MED Research in hematology. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-10-17T10:58:36.760000-04:00
1302228 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8f18dd39-e2e9-4a6c-a68b-4c823be64243 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION OF AMERICA'S BLOOD BANKS 2012 third_quarter MED Blood safety and management issues. HHS Advisory Committee on Blood Safety and Availability. Research related to Biovigilance. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-17T11:02:46.897000-04:00
1302273 DESIMONE CONSULTING, LLC 69ab41ef-f4e7-4f18-8a91-5d7ab1ce7478 Q3 DESIMONE CONSULTING, LLC 400931695 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 third_quarter MED Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-10-17T11:09:07.217000-04:00
1302384 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 620202c3-0809-4fa2-a6e8-df1432ae2eb1 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2012 third_quarter MED Hemophilia research, prevention, surveillance and service programs and issues. HR1919 Bleeding Disorders Screening Awareness and Further Education Act of 2011 Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2012-10-17T11:22:02.093000-04:00
1302401 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b1a800cb-ab48-498b-b1c5-0188d6d5a1f3 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2012 third_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2012-10-17T11:24:10.340000-04:00
1302801 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f1a09994-8a4d-4b76-a566-2225872503b2 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 STATE UNIVERSITY SYSTEM OF FLORIDA 2012 third_quarter MED Appropriations and Authorization legislation for FY 2013 in health care Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE 70000   0 0 2012-10-17T12:48:57.257000-04:00
1302948 THE PETRIZZO GROUP, INC. b7104881-d2fd-4d25-8074-037f1bac30d5 Q3 THE PETRIZZO GROUP, INC. 305932 ORLANDO HEALTH 2012 third_quarter MED -Concerns with issues surrounding the Medicaid expansion of the ACA and Disproportionate Share Hospital (DSH) cuts. -Concerns with issues regarding Medicaid being used as an offset for tax cuts and sequestration. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-17T13:37:58.713000-04:00
1303177 FIRST STRATEGIC 27ff35c2-c3c5-45f7-8606-358f49886aef Q3 FIRST STRATEGIC 91091 PHOENIX CHILDREN'S HOSPITAL 2012 third_quarter MED Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-17T14:14:24.437000-04:00
1303241 FIRST STRATEGIC a2065b01-9d6b-4380-9354-5edccc035ad3 Q3 FIRST STRATEGIC 91091 TRANSLATIONAL GENOMICS RESEARCH INSTITUTE 2012 third_quarter MED The Creating Hope Act - issues regarding drug development for pediatric rare diseases. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-10-17T14:22:52.110000-04:00
1303327 PHOENIX CHILDREN'S HOSPITAL be0ed283-6b72-4859-8e47-5426ad8e49f9 Q3 PHOENIX CHILDREN'S HOSPITAL 400381743 PHOENIX CHILDREN'S HOSPITAL 2012 third_quarter MED Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS. HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2012-10-17T14:32:33.443000-04:00
1303520 LIFE TECHNOLOGIES CORPORATION 648ff068-83ba-4b6a-95b2-d442c3330d82 Q3 LIFE TECHNOLOGIES CORPORATION 400391833 LIFE TECHNOLOGIES CORPORATION 2012 third_quarter MED Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. Unique Device Identifier proposed rule; Provisions regarding date format. HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2012-10-17T14:47:41.083000-04:00
1303537 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE c5375972-3891-4cde-9b67-dd18e6deae6c Q3 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE 400382759 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE 2012 third_quarter MED The Preservation of Antibiotics for Medical Treatment Act-HR 965/S.1211 HOUSE OF REPRESENTATIVES,SENATE   32948 0 0 2012-10-17T14:48:46.177000-04:00
1303666 THE PETRIZZO GROUP, INC. 85f6be37-7a07-42d1-88b6-2f44167151d2 Q3 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2012 third_quarter MED -Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding. -Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-17T15:07:38.983000-04:00
1303686 NATIONAL RIGHT TO LIFE COMMITTEE 20018c8a-682a-4c35-b63b-97233b083a0e Q3 NATIONAL RIGHT TO LIFE COMMITTEE 28481 NATIONAL RIGHT LIFE COMMITTEE 2012 third_quarter MED Reviewed H.R. 2104 ("Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act," "CARE Act"); suggested possible amendments. HOUSE OF REPRESENTATIVES,SENATE   99173 0 0 2012-10-17T15:10:44.757000-04:00
1303838 WHITMER & WORRALL, LLC 46d0d352-7b6e-4b54-a1f7-a0466f89f688 Q3 WHITMER & WORRALL, LLC 292892 NEURO KINETICS 2012 third_quarter MED Issues related to Traumatic Brain Injury (TBI). Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2012-10-17T15:27:38.347000-04:00
1303961 PRIME POLICY GROUP cd7c9958-4460-4751-8db0-3f3d518db4de Q3 PRIME POLICY GROUP 400532589 VERAX BIOMEDICAL, INC. 2012 third_quarter MED Blood Safety Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-17T15:42:38.080000-04:00
1304101 PARRY, ROMANI, DECONCINI & SYMMS e390284b-18fa-46d6-bf50-8c4ab46cf514 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) 2012 third_quarter MED General discussions regarding the rauthorization of the Prescription Drug User Fee Act (PDUFA), S. 3187 and H.R. 5651; and education and awareness of vaccine production and infrastructure needs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-17T16:08:49.567000-04:00
1304207 MCDERMOTT WILL & SCHULTE LLP 0c02a6a1-a86e-4490-819e-c72d3aae0dff Q3 MCDERMOTT WILL & SCHULTE LLP 24338 GENOMIC HEALTH INC 2012 third_quarter MED FDA regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2012-10-17T16:27:35.247000-04:00
1304249 AMERICAN ASSOCIATION OF COLLEGES OF NURSING 4c8f9a23-b186-4ed3-91d0-4a98569eb7e0 Q3 AMERICAN ASSOCIATION OF COLLEGES OF NURSING 66911 AMERICAN ASSOCIATION OF COLLEGES OF NURSING 2012 third_quarter MED Lobbied Members of Congress to protect funding for research in the FY 2013 LHHS Appropriations through the National Institutes of Health, National Institute of Nursing Research, Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   20000 0 0 2012-10-17T16:42:55.370000-04:00
1304351 UNIVERSITY OF PITTSBURGH d94d5856-1664-4eec-b255-716a2f91eb60 Q3 UNIVERSITY OF PITTSBURGH 53356 UNIVERSITY OF PITTSBURGH 2012 third_quarter MED Increased funding for Autism research and academic Autism research centers through NIH HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2012-10-17T17:06:27.093000-04:00
1304384 FAEGRE DRINKER BIDDLE & REATH LLP 83a4a24a-e806-48b5-a0e4-7fe41c333523 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 SPINA BIFIDA ASSOCIATION 2012 third_quarter MED Spina Bifida Research and Awareness and Access to Care; Folic Acid Fortification. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 20000   0 0 2012-10-17T17:18:41.297000-04:00
1304418 BRACEWELL LLP 9087888f-48fa-41e4-9c09-c1d743914b28 Q3 BRACEWELL LLP 6837 AIR LIQUIDE USA LLC 2012 third_quarter MED Worked related to medical gases Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Treasury, Dept of 60000   0 0 2012-10-17T17:26:01.117000-04:00
1304435 FAEGRE DRINKER BIDDLE & REATH LLP 5f5f6678-64cc-4736-bb4d-a31f648402e0 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 CHILDREN'S CARDIOMYOPATHY FOUNDATION, INC. 2012 third_quarter MED H.R. 3625/S.2124 - The Cardiomyopathy Health, Education, Awareness, Risk Assessment, and Training in the Schools Act; Food and Drug Administration (FDA) Pediatric Device Research and Regulation; Cardiomyopathy Research Issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-17T17:31:09.080000-04:00
1304475 FAEGRE DRINKER BIDDLE & REATH LLP 576e481d-5ee2-4058-9bb0-005d73d56ef3 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 OVARIAN CANCER NATIONAL ALLIANCE 2012 third_quarter MED Ovarian Cancer Research and Awareness; Implementation of Johanna's Law. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB) 10000   0 0 2012-10-17T17:53:26.637000-04:00
1304517 FAEGRE DRINKER BIDDLE & REATH LLP f4fa1621-371b-4b8e-a6ea-389541b0d48a Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREECLAMPSIA FOUNDATION 2012 third_quarter MED Preeclampsia Research Issues; National Health Calendar Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2012-10-17T18:10:44.620000-04:00
1304559 FAEGRE DRINKER BIDDLE & REATH LLP bf74b8b5-5ed3-4965-aaff-a0ec9365f331 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREVENT BLINDNESS 2012 third_quarter MED Eye Disease and Vision Health; Treatment and Prevention of Blindness and Vision Loss. HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 10000   0 0 2012-10-17T18:23:59.887000-04:00
1304574 FAEGRE DRINKER BIDDLE & REATH LLP 6a748b5f-c563-46c2-bbf7-04845021b4f4 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 NATIONAL PSORIASIS FOUNDATION 2012 third_quarter MED H.R. 2033/S.1107 - Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011; Psoriasis Data Collection. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 50000   0 0 2012-10-17T18:35:04.997000-04:00
1304721 THORN RUN PARTNERS 8bea93af-5779-41ea-8fbb-9dcd87862fac Q3 THORN RUN PARTNERS 400534596 NOVARTIS CORPORATION 2012 third_quarter MED Issues related to biologics. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-17T23:52:26.403000-04:00
1304817 VAN SCOYOC ASSOCIATES 59a9684b-1ed5-4ca7-b537-adf49b8544ef Q3 VAN SCOYOC ASSOCIATES 39837 COALITION OF EPSCOR STATES 2012 third_quarter MED S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2013, Biomedical related research & development initiatives; research infrastructure; IDeA program; and clinical research. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,Natl Aeronautics & Space Administration (NASA),Natl Institutes of Health (NIH),SENATE 110000   0 0 2012-10-18T06:41:30.517000-04:00
1304828 VAN SCOYOC ASSOCIATES 0bd86cef-162f-481a-971e-92c8338a606d Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF ALABAMA SYSTEM 2012 third_quarter MED Funding for National Institutes of Health, and various institutes and bureaus thereof. Funding for Health Resources Services Administration. Funding for Department of Defense medical research programs HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2012-10-18T06:42:32.030000-04:00
1304878 MEHLMAN CONSULTING, INC. d60dc267-46b4-402a-bce8-e7c4c887db02 Q3 MEHLMAN CONSULTING, INC. 284950 MAYO CLINIC 2012 third_quarter MED NIH appropriations Clinical laboratory reimbursement Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-10-18T08:42:59.893000-04:00
1304998 FAEGRE DRINKER BIDDLE & REATH LLP 6cd89a61-ebf3-4d3d-bef6-5abb1e6fd896 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 SPINA BIFIDA ASSOCIATION 2012 third_quarter MED Spina Bifida Research and Awareness and Access to Care; Folic Acid Fortification. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 20000   0 0 2012-10-18T09:28:55.383000-04:00
1305017 FAEGRE DRINKER BIDDLE & REATH LLP 331b8015-9524-48a1-88a7-6b5a495c4290 3A FAEGRE DRINKER BIDDLE & REATH LLP 12631 SPINA BIFIDA ASSOCIATION 2012 third_quarter MED Spina Bifida Research and Awareness and Access to Care; Folic Acid Fortification. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 20000   0 0 2012-10-18T09:36:04.500000-04:00
1305200 AUX INITIATIVES, LLC fe870b13-fd20-4e2c-a1b3-9f665619a113 Q3 AUX INITIATIVES, LLC 400384779 NOVARTIS VACCINES 2012 third_quarter MED Menococcal meningitis vaccine approval. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-10-18T10:04:21.373000-04:00
1305279 O'NEILL, ATHY & CASEY, P.C. 3d4be442-0f10-43fd-bb1d-0c49a28d98ad Q3 O'NEILL, ATHY & CASEY, P.C. 42752 COALITION OF BOSTON TEACHING HOSPITALS 2012 third_quarter MED Funding for federally-sponsored medical research HOUSE OF REPRESENTATIVES,SENATE 110000   0 0 2012-10-18T10:20:51.213000-04:00
1305384 FAEGRE DRINKER BIDDLE & REATH LLP 85c46eee-2c65-4b24-8f1c-be09069fe1c2 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2012 third_quarter MED Public Health Programs for Infectious and Tropical Disease; Department of Defense Tropical Medicine Research; National Institutes of Health Tropical Medicine Programs; S. Res. 429 - World Malaria Day Resolution. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-18T10:36:30.757000-04:00
1305406 O'NEILL, ATHY & CASEY, P.C. 775aa327-9557-4fda-84c6-9e4e6ec44c20 Q3 O'NEILL, ATHY & CASEY, P.C. 42752 MASS GENERAL BRIGHAM 2012 third_quarter MED Funding for federally-sponsored medical research HOUSE OF REPRESENTATIVES,SENATE 140000   0 0 2012-10-18T10:43:38.607000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2366.886ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API